Form CORRESP - Correspondence:
SEC Accession No. 0001104659-25-069322
Filing Date
2025-07-21
Accepted
2025-07-21 16:21:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6924
  Complete submission text file 0001104659-25-069322.txt   7938
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)